David Shaw’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
David Shaw's NAGE Position: Q3 2026 in Review
David Shaw reduced its Niagen Bioscience (NAGE) stake by 34% in Q3 2026, selling an estimated $110K and leaving 65,502 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #4643.
David Shaw first reported a position in NAGE in Q2 2021 and has held it in 18 quarters since. The position peaked at $23.1M in Q2 2025. 122 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- David Shaw held 65,502 shares of Niagen Bioscience worth $191K as of Q3 2026.
- David Shaw sold 34,436 Niagen Bioscience shares in Q3 2026, an estimated $110K.
- Niagen Bioscience made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4643 holding.
- David Shaw first reported a position in Niagen Bioscience in Q2 2021 and has held it in 18 quarters since.
- David Shaw's Niagen Bioscience position peaked at $23.1M in Q2 2025.
- 122 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.